Debut Plus

₹24.88

▲ +1.01 +4.23%

As of 23 Oct 2026 · delayed

NSE Listed

Fischer Medical Venture Limited (FISCHER)

Volume: 91,74,215Avg Vol 1W: 30,18,580Avg Vol 1M: 11,73,447.7552W Range:₹21.78₹121.7
Market Cap₹1,738 Cr
Current Price₹24.88
Previous Close₹23.87
High / Low (52w)₹121.7 / ₹21.78
Volume91,74,215
Avg Vol (1W)30,18,580
Avg Vol (1M)11,73,447.75
Stock P/E71.09
Book Value₹6.99
Dividend Yield2%
ROE8.06%
ROA365.2%
Revenue (TTM)₹321 Cr
Revenue Growth427.6%
Profit Margin6.67%
Total Debt₹0 Cr
Shares Outstanding70 Cr
Face Value₹1
EPS (TTM)₹0.35
P/B3.57
Debt / Equity0.27
50 DMA₹33.92
200 DMA₹36.78
Day change+4.23%
Price Chart
₹24.88▼ 77.60% · 1Y
₹118₹241.6Cr
2025-10-27
2026-10-23

20-day avg volume: 11.7L shares

Pros
  • Pays a dividend yield of 2.0%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 71.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹40 Cr₹12 Cr₹49 Cr₹23 Cr₹86 Cr₹101 Cr₹98 Cr₹82 Cr
EBITDA₹0 Cr₹0 Cr₹2 Cr₹11 Cr₹18 Cr₹22 Cr₹-4 Cr₹11 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹14 Cr₹19 Cr₹-12 Cr₹4 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹5 Cr₹112 Cr₹5 Cr₹7 Cr₹1 Cr₹4 Cr₹321 Cr₹1 Cr
EBITDA₹-1 Cr₹3 Cr₹1 Cr₹3 Cr₹-1 Cr₹-9 Cr₹52 Cr₹-2 Cr
Net Profit₹-1 Cr₹1 Cr₹-1 Cr₹1 Cr₹-2 Cr₹-9 Cr₹32 Cr₹-3 Cr
EPS—0.08————0.45—
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹86 Cr₹457 Cr₹671 Cr
Total Liabilities₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹120 Cr₹286 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹81 Cr₹338 Cr₹385 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹0 Cr₹-7 Cr₹-85 Cr₹-84 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹-31 Cr₹-125 Cr₹-5 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹37 Cr₹315 Cr₹14 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-7 Cr₹-85 Cr₹-111 Cr
Shareholding
Promoter 63.09% Institutions 6.71% Public 30.2%
Efficiency & Working Capital
ROCE10.6%
Interest Coverage9
Dividend Payout—
Debtor Days342 d
Inventory Days15 d
Payable Days121 d
Cash Conversion Cycle235 d
Working Capital Days357 d
Shareholding Details

As of 2026-09-30

Promoter63.1%
FII6.7%
DII0%
Institutions6.7%
Public30.2%
Promoter Pledge6.8%
No. of Shareholders25,676
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2025Apr 2025Apr 2025Jun 2025Jul 2025Jul 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026Sept 2026
Promoters62.8%61.8%61.8%61.8%61.8%61.8%61.8%61.8%62.1%62.1%63.1%63.1%
FIIs5.2%5.4%5.4%5.6%5.6%5.6%5.6%4.9%5%5.5%5.6%6.7%
DIIs1.4%1.4%1.4%1.4%1.4%0%1.4%1.4%1.4%1.3%1.3%0%
Public30.5%31.4%31.4%31.2%31.2%32.6%31.2%32%31.5%31%30.1%30.2%
Promoter Pledge0%0%0%0%0%0%0%0%7.4%7.4%6.8%6.8%
No. of Shareholders10,18010,18210,18210,05810,05010,05013,05422,92023,26923,95023,95125,676
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Fmv Holdings Pte LtdShareholding of Promoter and Promoter Group50.8%35.48 Cr
Shankar VaradharajanShareholding of Promoter and Promoter Group12.3%8.60 Cr
Vikasa India Eif I FundPublic Shareholding2.8%1.97 Cr
Roopal Hitesh Kawa .Public Shareholding2.5%1.73 Cr
India Emerging Giants Fund LimitedPublic Shareholding2.3%1.62 Cr
Maybank Securities Pte Ltd - OdiPublic Shareholding1.4%1.00 Cr
Blue Lotus Capital Multi Bagger Fund IiPublic Shareholding1.3%88,15,820
Vinay Rajendrakumar NagdaPublic Shareholding1.2%80,76,854
Natwarlal Keshavjibhai KawaPublic Shareholding1.1%77,38,320
Vritti Hitesh Kawa .Public Shareholding1%71,70,000
Hitesh Natwarlal KawaPublic Shareholding1%71,56,790
Ks Smart Technologies LtdShareholding of Promoter and Promoter Group0%0
Ravindran GovindanShareholding of Promoter and Promoter Group0%0
Mercatus Capital Pte LtdShareholding of Promoter and Promoter Group0%0
Time Medical Holdings Company LtdShareholding of Promoter and Promoter Group0%0
Eight Mercatus Pte. LtdShareholding of Promoter and Promoter Group0%0
Neuome Peptides Pte LtdShareholding of Promoter and Promoter Group0%0
Mercatus Medtech Pte LtdShareholding of Promoter and Promoter Group0%0
Infinite Diagnostics Pte LtdShareholding of Promoter and Promoter Group0%0
Eight Mighty Ventures Pte LtdShareholding of Promoter and Promoter Group0%0
Eight Ndx Ventures Pte LtdShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Shankar Varadharajan3.00 Cr34.9%2026-09-30
Board of Directors
NameDesignationYear
RAVINDRAN GOVINDANED / MD / Promoter2025
Svetlana RaoE D & Wholetime Director2025
Sanjay Jayantilal JainIndependent Non Exe. Director2025
Khairy Jamaluddin Abu BakkarIndependent Non Exe. Director2025
Jacob ThomasIndependent Non Exe. Director2025
Roberto M PagdangananIndependent Non Exe. Director2025
JAYA ANKUR SINGHANIAIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10806565
Corporate Actions
TypeDateValueRemark
dividend2026-09-22₹0.05 (5%)Final
forthcoming2026-09-22Dividend—
forthcoming2026-08-14Board Meetings—
dividend2025-09-22₹0.005 (0.5%)Final
split2025-09-121:10face value change from 10 to 1
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20263360010337
202620000020
20263150010316
Insider / Designated-Person Trades

11 recent disclosure(s)

FMV Holdings Pte LtdAcquisition · 4,54,210
FMV Holdings Pte LtdAcquisition · 73,35,909
Shankar VaradharajanAcquisition · 60,00,000
FMV Holdings Pte LtdAcquisition · 97,78,217
Shankar VaradharajanAcquisition · 15,00,000
FMV Holdings Pte LtdAcquisition · 54,31,664
Substantial Acquisitions (SAST)

5 disclosure(s)

Pref. Allotment17/08/2026 · 4,54,210
Pref. Allotment14/08/2026 · 1,33,35,909
Pref. Allotment13/08/2026 · 1,12,78,217
Pref. Allotment12/8/2026 · 66,31,664
Pref. Allotment11/8/2026 · 23,00,000
Company Information
Incorporated1993
AuditorBilimoria Mehta and Co
Investor Email[email protected]
🌐 www.fischerchemic.in ↗

📍 104 1st Fl Bhhind Poisar Depot, Raghuleela Mall Kandivali (W), Mumbai, Maharashtra, 400067

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search